<p>CytoMed Therapeutics Ltd. announced that its Executive Chairman, Peter Choo, increased his effective holdings in the company to 21.95% through recent open-market purchases of 105,824 shares. With these transactions and his existing personal stake of 187,500 shares, along with indirect holdings through Glorious Finance Limited and EP Capital Inc, Choo now owns a total of 2,388,246 shares. The price per share was not disclosed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-018869), on October 22, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

GDTC

<p>CytoMed Therapeutics Ltd. announced that Executive Chairman Peter Choo has increased his stake in the company to 21.95% by purchasing 105,824 shares in the open market. This brings his total ownership to 2,388,246 shares, including his existing personal stake and indirect holdings. The share price was not disclosed.</p>

CytoMed Therapeutics Chairman Buys 105,824 Shares, Raises Stake to 21.95%